title: A National Survey of State Medicaid Psychotropic-Monitoring Programs Targeting Youths.
abstract: This study aimed to describe state Medicaid psychotropic-monitoring programs targeting youths.
  
  
  
  Key informants from each state Medicaid administration and the District of Columbia were invited to participate in a telephone-administered survey designed to assess the implementation strategies of the state psychotropic-monitoring program. Data were collected from August 2011 through December 2012. A total of 38 states participated, four declined, and nine did not respond to the invitation. Descriptive statistics were used to characterize monitoring programs.
  
  
  
  Key informants from 28 of the 38 states (74%) reported a program in place, mostly prior authorization (68%). One-third of the programs (32%) had a two-tier review involving pharmacists and child psychiatrists.
  
  
  
  Although variability in psychotropic-monitoring programs may limit comparison of program impact across states, the variability provides an opportunity to investigate the impact of different models on best practices and the quality of care.
authors.affiliation: Except for Dr. Reeves, the authors are with the Department of Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, Baltimore (e-mail: sdosreis@rx.umaryland.edu ). Dr. Reeves is with the Department of Psychiatry, University of Maryland School of Medicine, Baltimore.
authors.forename: Susan
authors.initials: S
authors.lastname: dosReis
authors.affiliation: Except for Dr. Reeves, the authors are with the Department of Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, Baltimore (e-mail: sdosreis@rx.umaryland.edu ). Dr. Reeves is with the Department of Psychiatry, University of Maryland School of Medicine, Baltimore.
authors.forename: Ming-Hui
authors.initials: MH
authors.lastname: Tai
authors.affiliation: Except for Dr. Reeves, the authors are with the Department of Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, Baltimore (e-mail: sdosreis@rx.umaryland.edu ). Dr. Reeves is with the Department of Psychiatry, University of Maryland School of Medicine, Baltimore.
authors.forename: Wendy Castillo
authors.initials: WC
authors.lastname: Camelo
authors.affiliation: Except for Dr. Reeves, the authors are with the Department of Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, Baltimore (e-mail: sdosreis@rx.umaryland.edu ). Dr. Reeves is with the Department of Psychiatry, University of Maryland School of Medicine, Baltimore.
authors.forename: Gloria
authors.initials: G
authors.lastname: Reeves
mesh_terms: D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D016903:Drug Monitoring / Q000379:methods*; D005260:Female; D019538:Health Care Surveys; D006801:Humans; D007223:Infant; D008297:Male; D008484:Medicaid; D011619:Psychotropic Drugs / Q000627:therapeutic use*; D014481:United States
chemical_list: D011619:Psychotropic Drugs